Safety Lancet Market Poised for Significant Growth Driven by Rising Chronic Diseases and Demand for Painless Solutions
Explore the booming safety lancet market driven by rising chronic diseases, aging populations, and the demand for painless blood sampling.
VANCOUVER, BC, CANADA, June 10, 2024 /EINPresswire.com/ -- The global safety lancet market size was USD 1.88 Billion in 2022 and is expected to register a revenue CAGR of 10.5% during the forecast period. The safety lancet market is experiencing robust growth due to several key factors including the rising prevalence of chronic diseases, an aging global population, and the increasing demand for point-of-care testing. Safety lancets are becoming a critical tool for obtaining blood samples in a convenient and less painful manner, which is especially important for individuals needing to monitor their blood glucose levels multiple times daily.
Request a Sample Report with Table of Contents and Figures to click Here: @https://www.emergenresearch.com/request-sample/2858
Market Drivers
The growing incidence of chronic diseases such as diabetes, cancer, heart disease, and stroke is a major factor accelerating the market’s revenue expansion. According to the World Health Organization (WHO), noncommunicable diseases account for 74% of all deaths globally. Safety lancets play a crucial role in facilitating regular and safe blood sampling for individuals with these conditions.
Additionally, the adoption of painless safety lancets is significantly increasing. These devices are essential for collecting capillary blood samples to test for serious health conditions in neonates and are becoming popular because they cause minimal pain and anxiety. Companies are actively developing new, painless safety lancets. For instance, on March 22, 2023, Pip Diabetes launched a new line of painless lancets, featuring a preloaded hidden needle to minimize discomfort.
Market Restraints
Despite the promising growth, the market faces challenges such as stringent product testing and commercialization requirements. Regulatory authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have rigorous approval processes that can slow market expansion. Furthermore, the risk of spreading infections due to blood traces is a significant concern, as diseases like Hepatitis B and HIV-1 can be transmitted through contaminated lancets.
Market Segments
The global safety lancet market is segmented by type and end-use. Among types, the pressure-activated safety lancet segment held the largest market share in 2022. These lancets are designed to take blood samples for capillary tests while minimizing the risk of needlestick injuries. The side button safety lancet segment is expected to register the fastest growth due to the increasing need for blood glucose monitoring driven by chronic disease management.
In terms of end-use, hospitals and clinics dominate the market due to their extensive use of safety lancets for point-of-care testing and their compatibility with safety protocols. This segment benefits from the simplicity and effectiveness of safety lancets in providing fast diagnostic results, enhancing patient safety and treatment outcomes. The home diagnostics segment is expected to grow the fastest, fueled by the increasing demand for at-home blood glucose testing among diabetic patients.
For More Details On this Report Click Here @https://www.emergenresearch.com/industry-report/safety-lancet-market
Safety Lancet Top Companies and Competitive Landscape
The global safety lancet market is fragmented, with several key players accounting for the majority of market revenue. Major players are deploying various strategies, entering mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing new products and solutions.
Hoffmann-La Roche Ltd
Becton, Dickinson and Company
Terumo Corporation
Bayer AG
MTD Medical Technology and Devices S.p.A.
SARSTEDT AG & Co. KG
Improve Medical
Eli Lilly and Company
Ypsomed AG
Braun SE
Greiner Bio-One International GmbH
Abbott
Owen Mumford
Smith’s Group plc
Nipro Europe Group Companies
Cardinal Health
Roche Diabetes Care Limited
HTL
MediPurpose
Medtronic
Athersys, Inc
Safety Lancet Latest Industry Updates
On 19 September 2023, Tasso Inc, a leading patient-centric clinical-grade blood collection solution provider announced the CE Mark certification for their new product Tasso plus, a pain free safety blood lancets that collects whole blood liquid samples.
On 13 May 2022, The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, a new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It is indicated as an adjunct to diet and exercise to enhance glycaemic control in adults diagnosed with type 2 diabetes. The U.S. FDA-approved GIP and GLP-1 receptor agonist.
To Customized Report Market: @https://www.emergenresearch.com/request-for-customization/2858
Safety Lancet Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global safety lancet market on the basis of type, end-use, and region:
Type Outlook (Revenue, USD Billion; 2019-2032)
Push Button safety lancet
Pressure activated safety lancet
Side button safety lancet
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals and clinics
Diagnostic centres and pathology laboratories
Home diagnostic
Others
Regional Outlook (Revenue, USD Billion; 2019–2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Click Here To Buy Now @https://www.emergenresearch.com/select-license/2858
Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
View Additional Related Reports:
Chromatography Reagents Market
https://www.emergenresearch.com/industry-report/chromatography-reagents-market
Tokenization Market
https://www.emergenresearch.com/industry-report/tokenization-market
Smart Clothing Market
https://www.emergenresearch.com/industry-report/smart-clothing-market
Hemostats Market
https://www.emergenresearch.com/industry-report/hemostats-market
Wearable Technology Market
https://www.emergenresearch.com/industry-report/wearable-technology-market
Wearable Tattoo Monitors Market
https://www.emergenresearch.com/industry-report/wearable-tattoo-monitors-market
Digital Pathology Market
https://www.emergenresearch.com/industry-report/digital-pathology-market
Noninvasive Hemoglobin Monitoring Devices Market
https://www.emergenresearch.com/industry-report/noninvasive-hemoglobin-monitoring-devices-market
Allantoin Market
https://www.emergenresearch.com/industry-report/allantoin-market
Biodegradable Films Market
https://www.emergenresearch.com/industry-report/biodegradable-films-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.